{"transactions":[{"id":4134709,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":1,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":2,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":3,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":5,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-12T16:20:26.000Z","date":"2017-12-08","kind":"sale","acquired":false,"shares":19650,"price":17.34,"value":340731.0,"ownership":{"direct":false,"nature":"By LCA"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This report is filed jointly by Longitude Capital Partners, LLC (\"LCP\"), Longitude Venture Partners, L.P. (\"LVP\"), Longitude Capital Associates, L.P. (\"LCA\"), Patrick G. Enright (\"Enright\") and Juliet Tammenoms Bakker (\"Bakker\"). LCP is the general partner of LVP and LCA, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of Enright and Bakker is a managing member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of LCP, Enright and Bakker disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of their respective pecuniary interest therein."}],"balance_after":45620,"source":{"system":"sec-edgar","filing":"0001209191-17-065191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430719/000120919117065191/doc4.xml","form_type":"4"}},{"id":4134708,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":1,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":2,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":3,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":5,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-12T16:20:26.000Z","date":"2017-12-08","kind":"sale","acquired":false,"shares":980350,"price":17.34,"value":16999269.0,"ownership":{"direct":false,"nature":"By LVP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This report is filed jointly by Longitude Capital Partners, LLC (\"LCP\"), Longitude Venture Partners, L.P. (\"LVP\"), Longitude Capital Associates, L.P. (\"LCA\"), Patrick G. Enright (\"Enright\") and Juliet Tammenoms Bakker (\"Bakker\"). LCP is the general partner of LVP and LCA, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of Enright and Bakker is a managing member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of LCP, Enright and Bakker disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of their respective pecuniary interest therein."}],"balance_after":2276222,"source":{"system":"sec-edgar","filing":"0001209191-17-065191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430719/000120919117065191/doc4.xml","form_type":"4"}},{"id":4539085,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-12-01T02:52:15.000Z","date":"2016-11-28","kind":"other","acquired":false,"shares":58950,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By LCA"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution from LCA to its partners for no consideration.  LCP, which is the sole general partner of LCA, received a pro rata allocation of the distributed shares in accordance with its ownership."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by LCA. This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":121153,"source":{"system":"sec-edgar","filing":"0001209191-16-152569","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116152569/doc4.xml","form_type":"4"}},{"id":4539084,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-12-01T02:52:15.000Z","date":"2016-11-28","kind":"other","acquired":false,"shares":2941050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution from Longitude Venture Partners, L.P. (\"LVP\") to its partners for no consideration. Longitude Capital Partners, LLC (\"Longitude Capital\"), the sole general partner of LVP, received a pro rata allocation of the distributed shares in accordance with its ownership."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by LVP. This report is filed jointly by LVP, Longitude Capital, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":10834849,"source":{"system":"sec-edgar","filing":"0001209191-16-152569","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116152569/doc4.xml","form_type":"4"}},{"id":4542334,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-26T02:08:18.000Z","date":"2016-11-25","kind":"sale","acquired":false,"shares":290,"price":9.3869,"value":2722.201,"ownership":{"direct":false,"nature":"By LCA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.3000 to $9.4600. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. (\"LCA\"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":180103,"source":{"system":"sec-edgar","filing":"0001209191-16-152057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116152057/doc4.xml","form_type":"4"}},{"id":4542333,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-26T02:08:18.000Z","date":"2016-11-25","kind":"sale","acquired":false,"shares":14451,"price":9.3869,"value":135650.0919,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.3000 to $9.4600. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. (\"LVP\"). This report is filed jointly by LVP, Longitude Capital Partners, LLC (\"Longitude Capital\"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":13775899,"source":{"system":"sec-edgar","filing":"0001209191-16-152057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116152057/doc4.xml","form_type":"4"}},{"id":4542332,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-26T02:08:18.000Z","date":"2016-11-23","kind":"sale","acquired":false,"shares":248,"price":9.3038,"value":2307.3424,"ownership":{"direct":false,"nature":"By LCA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.3000 to $9.3400. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. (\"LCA\"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":180393,"source":{"system":"sec-edgar","filing":"0001209191-16-152057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116152057/doc4.xml","form_type":"4"}},{"id":4542331,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-26T02:08:18.000Z","date":"2016-11-23","kind":"sale","acquired":false,"shares":12352,"price":9.3038,"value":114920.5376,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.3000 to $9.3400. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. (\"LVP\"). This report is filed jointly by LVP, Longitude Capital Partners, LLC (\"Longitude Capital\"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":13790350,"source":{"system":"sec-edgar","filing":"0001209191-16-152057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116152057/doc4.xml","form_type":"4"}},{"id":4542330,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-26T02:08:18.000Z","date":"2016-11-22","kind":"sale","acquired":false,"shares":189,"price":9.3297,"value":1763.3133,"ownership":{"direct":false,"nature":"By LCA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.300 to $9.3600. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. (\"LCA\"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":180641,"source":{"system":"sec-edgar","filing":"0001209191-16-152057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116152057/doc4.xml","form_type":"4"}},{"id":4542329,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-26T02:08:18.000Z","date":"2016-11-22","kind":"sale","acquired":false,"shares":9411,"price":9.3297,"value":87801.8067,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.300 to $9.3600. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. (\"LVP\"). This report is filed jointly by LVP, Longitude Capital Partners, LLC (\"Longitude Capital\"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":13802702,"source":{"system":"sec-edgar","filing":"0001209191-16-152057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116152057/doc4.xml","form_type":"4"}},{"id":4547452,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-22T02:10:30.000Z","date":"2016-11-21","kind":"sale","acquired":false,"shares":2327,"price":9.386,"value":21841.222,"ownership":{"direct":false,"nature":"By LCA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.3300 to $9.4800. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. (\"LCA\"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":180830,"source":{"system":"sec-edgar","filing":"0001209191-16-151526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116151526/doc4.xml","form_type":"4"}},{"id":4547451,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-22T02:10:30.000Z","date":"2016-11-21","kind":"sale","acquired":false,"shares":116058,"price":9.386,"value":1089320.388,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.3300 to $9.4800. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. (\"LVP\"). This report is filed jointly by LVP, Longitude Capital Partners, LLC (\"Longitude Capital\"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":13812113,"source":{"system":"sec-edgar","filing":"0001209191-16-151526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116151526/doc4.xml","form_type":"4"}},{"id":4547450,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-22T02:10:30.000Z","date":"2016-11-18","kind":"sale","acquired":false,"shares":1976,"price":9.4736,"value":18719.8336,"ownership":{"direct":false,"nature":"By LCA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.4500 to $9.5400. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. (\"LCA\"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":183157,"source":{"system":"sec-edgar","filing":"0001209191-16-151526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116151526/doc4.xml","form_type":"4"}},{"id":4547449,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-22T02:10:30.000Z","date":"2016-11-18","kind":"sale","acquired":false,"shares":98586,"price":9.4736,"value":933964.3296,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.4500 to $9.5400. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. (\"LVP\"). This report is filed jointly by LVP, Longitude Capital Partners, LLC (\"Longitude Capital\"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":13928171,"source":{"system":"sec-edgar","filing":"0001209191-16-151526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116151526/doc4.xml","form_type":"4"}},{"id":4547448,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-22T02:10:30.000Z","date":"2016-11-17","kind":"sale","acquired":false,"shares":6389,"price":9.6434,"value":61611.6826,"ownership":{"direct":false,"nature":"By LCA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5300 to $9.8000. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. (\"LCA\"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":185133,"source":{"system":"sec-edgar","filing":"0001209191-16-151526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116151526/doc4.xml","form_type":"4"}},{"id":4547447,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":2,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":4,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-22T02:10:30.000Z","date":"2016-11-17","kind":"sale","acquired":false,"shares":318764,"price":9.6434,"value":3073968.7576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5300 to $9.8000. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. (\"LVP\"). This report is filed jointly by LVP, Longitude Capital Partners, LLC (\"Longitude Capital\"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":14026757,"source":{"system":"sec-edgar","filing":"0001209191-16-151526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116151526/doc4.xml","form_type":"4"}},{"id":4550993,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":2,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":3,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-18T00:32:55.000Z","date":"2016-11-16","kind":"sale","acquired":false,"shares":342,"price":9.5087,"value":3251.9754,"ownership":{"direct":false,"nature":"By LCA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5000 to $9.5450. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. (\"LCA\"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":191522,"source":{"system":"sec-edgar","filing":"0001209191-16-151019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116151019/doc4.xml","form_type":"4"}},{"id":4550992,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":2,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":3,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-18T00:32:55.000Z","date":"2016-11-16","kind":"sale","acquired":false,"shares":17052,"price":9.5087,"value":162142.3524,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5000 to $9.5450. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. (\"LVP\"). This report is filed jointly by LVP, Longitude Capital Partners, LLC (\"Longitude Capital\"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":14345521,"source":{"system":"sec-edgar","filing":"0001209191-16-151019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116151019/doc4.xml","form_type":"4"}},{"id":4550991,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":2,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":3,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-18T00:32:55.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":3094,"price":9.5534,"value":29558.2196,"ownership":{"direct":false,"nature":"By LCA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5000 to $9.7200. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. (\"LCA\"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":191864,"source":{"system":"sec-edgar","filing":"0001209191-16-151019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116151019/doc4.xml","form_type":"4"}},{"id":4550990,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":171215,"kind":"organization","name":"Longitude Venture Partners L.P.","position":1,"cik":"0001419701","reported_name":"Longitude Venture Partners L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171214,"kind":"organization","name":"Longitude Capital Associates, L.P.","position":2,"cik":"0001430719","reported_name":"Longitude Capital Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":171213,"kind":"organization","name":"Longitude Capital Partners, LLC","position":3,"cik":"0001430720","reported_name":"Longitude Capital Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-18T00:32:55.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":154359,"price":9.5534,"value":1474653.2706,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5000 to $9.7200. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. (\"LVP\"). This report is filed jointly by LVP, Longitude Capital Partners, LLC (\"Longitude Capital\"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein."}],"balance_after":14362573,"source":{"system":"sec-edgar","filing":"0001209191-16-151019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000120919116151019/doc4.xml","form_type":"4"}}]}